Phathom
PHAT

Phathom (PHAT) analyst forecast and price target

Recent analyst ratings

FirmActionRatingPrice targetDate
BarclaysMaintainedOverweight$14.00 from $18.00Aug 17, 2026
HC Wainwright & Co.MaintainedBuy$26.00Jul 31, 2026
GuggenheimMaintainedBuy$22.00 from $25.00Jul 31, 2026
NeedhamMaintainedBuy$22.00 from $28.00Jul 30, 2026
HC Wainwright & Co.MaintainedBuy$26.00Jun 17, 2026
BarclaysUpgradedEqual-Weight → Overweight$18.00 from $16.00Mar 27, 2026
GuggenheimMaintainedBuy$25.00 from $20.00Feb 27, 2026
BarclaysInitiated CoverageEqual-Weight$16.00Dec 9, 2025
HC Wainwright & Co.MaintainedBuy$26.00 from $20.00Oct 31, 2025
HC Wainwright & Co.MaintainedBuy$20.00Jun 9, 2025
Craig-HallumMaintainedBuy$17.00 from $12.00Jun 9, 2025
NeedhamMaintainedBuy$28.00Jun 6, 2025
HC Wainwright & Co.MaintainedBuy$20.00 from $28.00May 2, 2025
GuggenheimMaintainedBuy$12.00 from $18.00May 2, 2025
Goldman SachsMaintainedNeutral$5.00 from $10.00May 2, 2025
NeedhamMaintainedBuy$28.00Apr 21, 2025
Goldman SachsMaintainedNeutral$10.00 from $12.00Apr 17, 2025
NeedhamMaintainedBuy$28.00Apr 9, 2025
NeedhamMaintainedBuy$28.00Apr 2, 2025
GuggenheimMaintainedBuyApr 2, 2025

Frequently asked questions

  • What is the latest analyst rating on PHAT?

    On Aug 17, 2026, Barclays maintained Phathom at Overweight with a price target of $14.00.

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.